Velan Capital Investment Management as of March 31, 2024
Portfolio Holdings for Velan Capital Investment Management
Velan Capital Investment Management holds 21 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alimera Sciences Com New | 24.0 | $53M | 14M | 3.90 | |
| Jasper Therapeutics Com New (JSPR) | 19.5 | $43M | 1.5M | 29.36 | |
| Praxis Precision Medicines I Com New (PRAX) | 9.7 | $21M | 351k | 61.02 | |
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 9.5 | $21M | 100k | 210.30 | |
| Heron Therapeutics (HRTX) | 8.7 | $19M | 7.0M | 2.77 | |
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 6.4 | $14M | 150k | 94.89 | |
| Adma Biologics (ADMA) | 4.6 | $10M | 1.5M | 6.60 | |
| Tourmaline Bio (TRML) | 3.3 | $7.3M | 319k | 22.90 | |
| Outlook Therapeutics (OTLK) | 2.7 | $6.0M | 500k | 11.94 | |
| Optinose (OPTN) | 2.0 | $4.4M | 3.0M | 1.46 | |
| Tela Bio (TELA) | 1.9 | $4.2M | 746k | 5.67 | |
| Inspire Med Sys (INSP) | 1.7 | $3.9M | 18k | 214.79 | |
| Aquestive Therapeutics (AQST) | 1.2 | $2.6M | 600k | 4.26 | |
| Elevation Oncology (ELEV) | 1.2 | $2.6M | 497k | 5.13 | |
| Inspiremd (NSPR) | 1.0 | $2.1M | 904k | 2.37 | |
| Geron Corporation (GERN) | 0.7 | $1.7M | 500k | 3.30 | |
| Milestone Pharmaceuticals (MIST) | 0.5 | $1.2M | 650k | 1.79 | |
| Rezolute Com New (RZLT) | 0.5 | $1.0M | 400k | 2.55 | |
| Envveno Medical (NVNO) | 0.4 | $937k | 172k | 5.44 | |
| Kiora Pharmaceuticals Com New | 0.4 | $777k | 1.1M | 0.71 | |
| Aslan Pharmaceuticals Spon Ads New (ASLN) | 0.2 | $385k | 625k | 0.62 |
